Detalles de la búsqueda
1.
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Ann Hematol;
2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805037
2.
Effects of the Host Plants of the Maize-Based Intercropping Systems on the Growth, Development and Preference of Fall Armyworm, Spodoptera frugiperda (Lepidoptera: Noctuidae).
Insects;
15(1)2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249032
3.
Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma.
Haematologica;
109(4): 1269-1273, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855035
4.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol;
102(9): 2459-2469, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306711
5.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Lancet Reg Health West Pac;
34: 100720, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283978
6.
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.
Blood Adv;
7(16): 4349-4357, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078706
7.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica;
108(9): 2467-2475, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951150
8.
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Cancer Rep (Hoboken);
6(5): e1800, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919649
9.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
EJHaem;
4(1): 78-89, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819187
10.
A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.
BMC Cancer;
22(1): 45, 2022 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996395
11.
[Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
29(6): 1785-1789, 2021 Dec.
Artículo
en Chino
| MEDLINE | ID: mdl-34893111
12.
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study.
Ann Hematol;
100(12): 2961-2968, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34331111
13.
[Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
28(3): 849-854, 2020 Jun.
Artículo
en Chino
| MEDLINE | ID: mdl-32552946
14.
Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome.
Oncotarget;
8(34): 56980-56990, 2017 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28915647
15.
Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas.
Med Oncol;
32(1): 353, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25511319
16.
[Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues].
Zhonghua Zhong Liu Za Zhi;
35(6): 450-5, 2013 Jun.
Artículo
en Chino
| MEDLINE | ID: mdl-24119906
17.
Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.
Expert Opin Drug Metab Toxicol;
9(2): 117-25, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23134084
18.
[Prognostic factors of nasal NK/T-cell lymphoma].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi;
48(12): 1011-6, 2013 Dec.
Artículo
en Chino
| MEDLINE | ID: mdl-24507001
19.
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
Zhonghua Zhong Liu Za Zhi;
34(4): 306-10, 2012 Apr.
Artículo
en Chino
| MEDLINE | ID: mdl-22781046
20.
Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.
Thorac Cancer;
3(1): 72-78, 2012 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28920255